ITIH3 and adrenal cortex carcinoma: Indeed, our work has shown that high ITIH3 expression is associated with reduced survival also in adrenocortical carcinoma, colon adenocarcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma and mesothelioma.